Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent trends in rifamycin research

R Lal1, S Lal

  • 1Department of Zoology, University of Delhi, India.

Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|March 1, 1994
PubMed
Summary

Rifamycin, an antibiotic from Amycolatopsis mediterranei, combats tuberculosis and leprosy by inhibiting RNA synthesis. Research explores new derivatives and recombinant DNA techniques to boost its production and effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of multidetector computed tomographybased component separation index in the management of large ventral hernias.

South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie·2024
Same author

Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Bovine viral diarrhoea viruses from New Zealand belong predominantly to the BVDV-1a genotype.

New Zealand veterinary journal·2024
Same author

CO<sub>2</sub>-C evolution rate in an incubation study with straw input to soil managed by different tillage systems.

RSC advances·2022
Same author

Energy and carbon budgeting of traditional land use change with groundnut based cropping system for environmental quality, resilient soil health and farmers income in eastern Indian Himalayas.

Journal of environmental management·2021
Same author

Towards a global-scale soil climate mitigation strategy.

Nature communications·2020

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pharmacology

Background:

  • Rifamycin is a crucial macrolide antibiotic produced by Amycolatopsis mediterranei.
  • It is primarily used to treat Mycobacterium tuberculosis and Mycobacterium leprae, the causative agents of tuberculosis and leprosy.
  • Rifamycin inhibits RNA synthesis by binding to the beta-subunit of RNA polymerase in these bacteria.

Purpose of the Study:

  • To review recent trends in rifamycin research.
  • To explore the application of recombinant DNA techniques for enhancing rifamycin production.
  • To highlight the growing importance and demand for rifamycin and its derivatives.

Main Methods:

  • Literature review of recent rifamycin research.
  • Analysis of recombinant DNA techniques applicable to antibiotic production.
  • Examination of rifamycin's mechanism of action and antiviral properties.

Main Results:

  • Rifamycin derivatives show efficacy against Mycobacterium avium, relevant to AIDS-associated infections.
  • Rifamycin's inhibitory effect on RNA synthesis and reverse transcriptase (RT) is confirmed.
  • Recombinant DNA technology offers potential for increased rifamycin yields.

Conclusions:

  • The demand for rifamycin is increasing globally due to its therapeutic applications.
  • Ongoing research focuses on expanding rifamycin's utility and improving its production methods.
  • Advancements in genetic engineering may significantly enhance the accessibility of this vital antibiotic.

Related Experiment Videos